File Browser

JANSSEN INC. ET AL. v. GENERIC MEDICAL PARTNERS INC.

Summary of T-140-23

The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.

Federal Court Type: Patented Medicines (NOC) Regulations [Actions]

Parties and Lawyers:
PartyFirmLawyer
ACTELION PHARMACEUTICALS LTD
GENERIC MEDICAL PARTNERS INC
JANSSEN INCBLAKE CASSELS & GRAYDON LLPSKODYN, ANDREW
Intellectual Property:
NameNumber
OPSUMIT
257221
2659770
2621273

Patented Medicine: Macitentan (Medicinal ingredients are based on automated analysis and should not be relied upon.)

Docket Summary (Google Translate to English)

(10) 2023-03-17 - Toronto
Solicitor's certificate of service on behalf of Dylan Churchill confirming service of Docs. 7 and 8 or 9 upon Defendant by email on 17-MAR-2023 filed on 17-MAR-2023
(9) 2023-03-17 - Toronto
Consent on behalf of all parties to Doc. 8 filed on 17-MAR-2023
(8) 2023-03-17 - Toronto
Discontinuance on behalf of Plaintiff filed on 17-MAR-2023
() 2023-02-15 - Ottawa
Acknowledgment of Receipt received from both parties with respect to doc 7 placed on file on 15-FEB-2023
(7) 2023-02-15 - Ottawa
DOWNLOAD Order (time and place) dated 15-FEB-2023 rendered by Chief Justice Crampton and signed by Judicial Administrator fixing Trial of the matter to be heard at Special Sitting in Toronto on 01-OCT-2024 to begin at 09:30 duration: 10j language: E Filed on 15-FEB-2023 cc's sent to parties entered in J. & O. Book, volume 1581 page(s) 445 - 445 Transmittal letters placed on file
() 2023-02-10 - Toronto
Letter from Plaintiff dated 10-FEB-2023 providing the court with an agenda for the CMC received on 10-FEB-2023
() 2023-02-10 - Toronto
Toronto 10-FEB-2023 BEFORE Trent Horne, Esq., Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: the Court will touch base with the Hearing Coordinator to arrange a 10 day hearing date held by way of Conference Call Duration per day: 10-FEB-2023 from 01:30 to 01:40 Courtroom : Judge's Chambers - Toronto Court Registrar: Shaun Nelson Total Duration: 10min Appearances: Mr. Meagher and Mr. Skodyn 416-863-2545 representing Plaintiff Mr. Clarizio 416-865-3518 representing Defendant Minutes of Hearing entered in Vol. 1091 page(s) 168 - 169 Abstract of Hearing placed on file
(6) 2023-02-09 - Toronto
Consent on behalf of all parties to electronic service filed on 09-FEB-2023
() 2023-02-03 - Toronto
Letter from Plaintiff dated 03-FEB-2023 re: parties' request for a CMC along with mutual dates of availablity received on 03-FEB-2023
(5) 2023-01-27 - Toronto
Solicitor's certificate of service on behalf of Dino P. Clarizio confirming service of Doc. 4 upon Defendant by email on 27-JAN-2023 filed on 27-JAN-2023
(4) 2023-01-27 - Toronto
Notice of Intention to Respond filed on 27-JAN-2023
() 2023-01-20 - Ottawa
Acknowledgment of Receipt received from all parties with respect to Doc 3 placed on file on 20-JAN-2023
(3) 2023-01-20 - Ottawa
DOWNLOAD Order dated 20-JAN-2023 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 18-JAN-2023 Result: "1. This proceeding shall continue as a specially managed proceeding. 2. Pursuant to Rule 383, Associate Judge Trent Horne is assigned as Case Management Judge in this matter." Filed on 20-JAN-2023 copies sent to parties entered in J. & O. Book, volume 1578 page(s) 44 - 45 Interlocutory Decision
() 2023-01-19 - Toronto
Acknowledgment of Receipt received from Plaintiff/Def sent by e-mail (awaiting conf) with respect to id 6 placed on file on 19-JAN-2023
() 2023-01-19 - Toronto
DOWNLOAD Oral directions received from the Court: Sylvie Molgat, Prothonotary dated 19-JAN-2023 directing that Counsel for the Defendant having confirmed receipt of the Statement of Claim issued and accepted service on behalf of the Generic Medical Partners Inc. on Jan. 18/23, service of the Claim is hereby validated. placed on file on 19-JAN-2023 Confirmed in writing to the party(ies)
() 2023-01-19 - Toronto
Communication to the Court from the Registry dated 19-JAN-2023 re: Plaintiff's letter id 3 sent for disposition
(2) 2023-01-18 - Toronto
Acknowledgment of Receipt received from Attorney General of Canada with respect to Statement of Claim, Doc 1 filed on 18-JAN-2023
() 2023-01-18 - Toronto
Letter from Plaintiff to Federal Court dated 18-JAN-2023 Requesting validation of service of the Statement of Claim upon the Defendant. The Defendant has agreed. received on 18-JAN-2023
() 2023-01-18 - Toronto
Letter from the Plaintiffs, Janssen Inc. et al. dated 18-JAN-2023 The Plaintiffs, Janssen Inc. et al. requests that this action be specially managed pursuant to section 6.10(1) of the Patent Medicines (Notice of Compliance) Regulations and Rules 383, 383.1 and 385 of the Federal Courts Rules. The Plaintiffs further request that a Case Management Judge be appointed. The three prior Federal Court actions involving the same drug: T-549-20 (JANSSEN INC. ET AL. v. SANDOZ CANADA INC.) T-555-20 (JANSSEN INC. ET AL. v. APOTEX INC.) T-769-20 (JANSSEN INC. ET AL. v. JAMP PHARMA CORPORATION) Associate Judge Horne was assigned as the Case Management Judge and the Honourable Justice Pallotta was assigned as the Trial Judge. cc: Charles Boulakia and Dino Clarizio (Counsel for GMP) received on 18-JAN-2023
(1) 2023-01-18 - Toronto
DOWNLOAD Statement of Claim filed on 18-JAN-2023 Certified copy(ies)/copy(ies) transmitted to Director of the Regional Office of the Department of Justice Tariff other action - $150.00

The official version of the court proceeding information is available from the court websites directly:
Browse another proceeding. Enter Court File No:

Canadian Intellectual Property